Variant Philadelphia translocations in CML: Correlation with fragile sites

Mario Sessarego, Raffaella Defferrari, Claudio Panarello, Francesco Frassoni, Paola Mandich, Franco Ajmar

Research output: Contribution to journalArticle

Abstract

Of 175 CML patients studied, 14 variants were found, seven of which are presently described. The breakpoints involved in the translocation, other than 9q34 and 22q11, are 3p21, 5q13, 6p21, 7q22, 10q22, 10q22, and 11p13. Fragile sites were investigated in some of these patients. In two cases a coincidence between fragile site location and breakpoint of the third chromosome involved in Philadelphia formation was found. This observation suggests that the fragile sites can lead to Ph variants in patients developing CML.

Original languageEnglish
Pages (from-to)105-112
Number of pages8
JournalCancer Genetics and Cytogenetics
Volume31
Issue number1
DOIs
Publication statusPublished - 1988

Fingerprint

Chromosome Breakpoints

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Variant Philadelphia translocations in CML : Correlation with fragile sites. / Sessarego, Mario; Defferrari, Raffaella; Panarello, Claudio; Frassoni, Francesco; Mandich, Paola; Ajmar, Franco.

In: Cancer Genetics and Cytogenetics, Vol. 31, No. 1, 1988, p. 105-112.

Research output: Contribution to journalArticle

Sessarego, Mario ; Defferrari, Raffaella ; Panarello, Claudio ; Frassoni, Francesco ; Mandich, Paola ; Ajmar, Franco. / Variant Philadelphia translocations in CML : Correlation with fragile sites. In: Cancer Genetics and Cytogenetics. 1988 ; Vol. 31, No. 1. pp. 105-112.
@article{16461513a51042f8a4d57217bfac97b3,
title = "Variant Philadelphia translocations in CML: Correlation with fragile sites",
abstract = "Of 175 CML patients studied, 14 variants were found, seven of which are presently described. The breakpoints involved in the translocation, other than 9q34 and 22q11, are 3p21, 5q13, 6p21, 7q22, 10q22, 10q22, and 11p13. Fragile sites were investigated in some of these patients. In two cases a coincidence between fragile site location and breakpoint of the third chromosome involved in Philadelphia formation was found. This observation suggests that the fragile sites can lead to Ph variants in patients developing CML.",
author = "Mario Sessarego and Raffaella Defferrari and Claudio Panarello and Francesco Frassoni and Paola Mandich and Franco Ajmar",
year = "1988",
doi = "10.1016/0165-4608(88)90017-9",
language = "English",
volume = "31",
pages = "105--112",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Variant Philadelphia translocations in CML

T2 - Correlation with fragile sites

AU - Sessarego, Mario

AU - Defferrari, Raffaella

AU - Panarello, Claudio

AU - Frassoni, Francesco

AU - Mandich, Paola

AU - Ajmar, Franco

PY - 1988

Y1 - 1988

N2 - Of 175 CML patients studied, 14 variants were found, seven of which are presently described. The breakpoints involved in the translocation, other than 9q34 and 22q11, are 3p21, 5q13, 6p21, 7q22, 10q22, 10q22, and 11p13. Fragile sites were investigated in some of these patients. In two cases a coincidence between fragile site location and breakpoint of the third chromosome involved in Philadelphia formation was found. This observation suggests that the fragile sites can lead to Ph variants in patients developing CML.

AB - Of 175 CML patients studied, 14 variants were found, seven of which are presently described. The breakpoints involved in the translocation, other than 9q34 and 22q11, are 3p21, 5q13, 6p21, 7q22, 10q22, 10q22, and 11p13. Fragile sites were investigated in some of these patients. In two cases a coincidence between fragile site location and breakpoint of the third chromosome involved in Philadelphia formation was found. This observation suggests that the fragile sites can lead to Ph variants in patients developing CML.

UR - http://www.scopus.com/inward/record.url?scp=0023818861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023818861&partnerID=8YFLogxK

U2 - 10.1016/0165-4608(88)90017-9

DO - 10.1016/0165-4608(88)90017-9

M3 - Article

C2 - 3125958

AN - SCOPUS:0023818861

VL - 31

SP - 105

EP - 112

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -